Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 1, Pages 62-71
Publisher
SAGE Publications
Online
2016-03-22
DOI
10.1177/1352458516639384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- CSF levels of YKL-40 are increased in MS and decrease with immunosuppressive treatment
- (2014) Clas Malmeström et al. JOURNAL OF NEUROIMMUNOLOGY
- Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation
- (2014) Debayon Paul et al. Journal of Neuroinflammation
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
- (2013) Signe Modvig et al. PLoS One
- Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)
- (2013) B.O. Khatri et al. Multiple Sclerosis and Related Disorders
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
- (2012) Virginia Devonshire et al. LANCET NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- (2010) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
- (2010) Grégory Conductier et al. JOURNAL OF NEUROIMMUNOLOGY
- Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
- (2010) M. Axelsson et al. JOURNAL OF NEUROLOGY
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis
- (2009) M. M. Verbeek et al. ACTA NEUROLOGICA SCANDINAVICA
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started